Espero maintains a comprehensive, ongoing Corporate Compliance Program (CCP) in accordance with all federal, state, and industry guidelines.
Among the guidelines used in creating our CCP are:
“Compliance Program Guidance for Pharmaceutical Manufacturers” (Office of Inspector General (OIG), U.S. Department of Health and Human Services
“Code on Interactions with Healthcare Professionals.”–Pharmaceutical Research and Manufacturers of America (PhRMA)
Our CCP also calls for continuous assessment of applicable statutes, regulations, program requirements and best practices to maintain compliance.